157 related articles for article (PubMed ID: 12085260)
1. High-risk human papillomavirus clearance in pregnant women: trends for lower clearance during pregnancy with a catch-up postpartum.
Nobbenhuis MA; Helmerhorst TJ; van den Brule AJ; Rozendaal L; Bezemer PD; Voorhorst FJ; Meijer CJ
Br J Cancer; 2002 Jul; 87(1):75-80. PubMed ID: 12085260
[TBL] [Abstract][Full Text] [Related]
2. [Human papilloma virus infection in pregnant women with normal pap-smears, HPV oncogenity and risk factors].
Nowak Z; Karowicz-Bilińska A
Ginekol Pol; 2007 Sep; 78(9):678-84. PubMed ID: 18159820
[TBL] [Abstract][Full Text] [Related]
3. Cervical human papillomavirus deoxyribonucleic acid persists throughout pregnancy and decreases in the postpartum period.
Fife KH; Katz BP; Brizendine EJ; Brown DR
Am J Obstet Gynecol; 1999 May; 180(5):1110-4. PubMed ID: 10329863
[TBL] [Abstract][Full Text] [Related]
4. The association between pregnancy and human papilloma virus prevalence.
Smith EM; Johnson SR; Jiang D; Zaleski S; Lynch CF; Brundage S; Anderson RD; Turek LP
Cancer Detect Prev; 1991; 15(5):397-402. PubMed ID: 1661203
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus infection in pregnant women.
Domža G; Gudlevičienė Z; Didžiapetrienė J; Valuckas KP; Kazbarienė B; Drąsutienė G
Arch Gynecol Obstet; 2011 Nov; 284(5):1105-12. PubMed ID: 21170544
[TBL] [Abstract][Full Text] [Related]
6. [Detection of the asymptomatic infection by human papillomavirus in pregnant women and neonates].
Peng P; Weng X; Gu Z
Zhonghua Fu Chan Ke Za Zhi; 2000 Sep; 35(9):523-6. PubMed ID: 11775940
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of human papilloma virus infection in pregnant Turkish women compared with non-pregnant women.
Aydin Y; Atis A; Tutuman T; Goker N
Eur J Gynaecol Oncol; 2010; 31(1):72-4. PubMed ID: 20349784
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of human papilloma virus infection of women in early pregnancy and postpartum].
Jin Y; Chen CR; Guo XY; Hu QL; Qin BF
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Apr; 31(4):709-10. PubMed ID: 21515477
[TBL] [Abstract][Full Text] [Related]
9. Serologic response to the E4, E6, and E7 proteins of human papillomavirus type 16 in pregnant women.
Sethi S; Müller M; Schneider A; Blettner M; Smith E; Turek L; Wahrendorf J; Gissmann L; Chang-Claude J
Am J Obstet Gynecol; 1998 Feb; 178(2):360-4. PubMed ID: 9500500
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated human papillomavirus types are selectively increased in the cervix of women in the first trimester of pregnancy.
Fife KH; Katz BP; Roush J; Handy VD; Brown DR; Hansell R
Am J Obstet Gynecol; 1996 May; 174(5):1487-93. PubMed ID: 9065116
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of human papillomavirus infection in pregnant versus non-pregnant women in Brazil.
Salcedo MM; Damin AP; Agnes G; Pessini SA; Beitune PE; Alexandre CO; Schmeler KM; da Silveira GP
Arch Gynecol Obstet; 2015 Dec; 292(6):1273-8. PubMed ID: 25990479
[TBL] [Abstract][Full Text] [Related]
12. Low incidence of human papillomavirus type 16 antibody seroconversion in young children.
Manns A; Strickler HD; Wikktor SZ; Pate EJ; Gray R; Waters D
Pediatr Infect Dis J; 1999 Sep; 18(9):833-5. PubMed ID: 10493350
[No Abstract] [Full Text] [Related]
13. Detection of urinary Chlamydia trachomatis, Mycoplasma genitalium and human papilloma virus in the first trimester of pregnancy by PCR method.
Rahimkhani M; Mordadi A; Gilanpour M
Ann Clin Microbiol Antimicrob; 2018 Jun; 17(1):25. PubMed ID: 29866110
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of antibody to human papilloma virus type 16 and risk of cervical, endometrial, and ovarian cancers (United States).
Hisada M; van den Berg BJ; Strickler HD; Christianson RE; Wright WE; Waters DJ; Rabkin CS
Cancer Causes Control; 2001 May; 12(4):335-41. PubMed ID: 11456229
[TBL] [Abstract][Full Text] [Related]
15. Trends in seroprevalence of human papillomavirus type 16 among pregnant women in Stockholm, Sweden, during 1969-1989.
af Geijersstam V; Wang Z; Lewensohn-Fuchs I; Eklund C; Schiller JT; Forsgren M; Dillner J
Int J Cancer; 1998 May; 76(3):341-4. PubMed ID: 9579570
[TBL] [Abstract][Full Text] [Related]
16. High-risk human papillomavirus detection and related risk factors among pregnant and nonpregnant women in Mexico.
Hernández-Girón C; Smith JS; Lorincz A; Lazcano E; Hernández-Avila M; Salmerón J
Sex Transm Dis; 2005 Oct; 32(10):613-8. PubMed ID: 16205302
[TBL] [Abstract][Full Text] [Related]
17. [Risk assessment of chronic HPV HR infection in babies who contacted the virus in the perinatal period].
Tarka A; Szczepańska M; Rokita W; Józefiak A; Kedzia W
Ginekol Pol; 2011 Sep; 82(9):664-9. PubMed ID: 22379925
[TBL] [Abstract][Full Text] [Related]
18. [Risk factors and frequency of occurrence of HPV DNA of high oncogenic types in paraepidermal epithelium cells of the uterine cervix, in the trophoblast, and in the peripheral blood of pregnant patients].
Tarka A; Szczepańska M; Raczyńska D; Pruski D; Kedzia W; Opala T
Ginekol Pol; 2008 Dec; 79(12):871-6. PubMed ID: 19175046
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus detection in pregnant women: a prospective matched cohort study.
Schmeink CE; Melchers WJ; Hendriks JC; Quint WG; Massuger LF; Bekkers RL
J Womens Health (Larchmt); 2012 Dec; 21(12):1295-301. PubMed ID: 23210493
[TBL] [Abstract][Full Text] [Related]
20. Frequency and types of human papillomavirus among pregnant and non-pregnant women with human immunodeficiency virus infection in Recife determined by genotyping.
Brandão Vda C; Lacerda HR; Lucena-Silva N; Ximenes RA
Mem Inst Oswaldo Cruz; 2009 Aug; 104(5):755-63. PubMed ID: 19820838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
